IκBα glutathionylation and reduced histone H3 phosphorylation inhibit eotaxin and RANTES

European Respiratory Journal

Volumn 38, Issue 6, 2011, Pages 1444-1452

  Seidel, P ^a   Roth, M ^c   Ge, Q ^b   Merfort, I ^d   S'ng, C T ^c   Ammit, A J ^a  

^a Faculty of Pharmacy   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Asthma; Glutathionylation; Histone H3; I B ; Mitogen and stress activated protein kinase 1

Indexed keywords

DIAMIDE; EOTAXIN; FUMARIC ACID DIMETHYL ESTER; GLUTATHIONE ETHYL ESTER; HISTONE H3; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; RANTES; STRESS ACTIVATED PROTEIN KINASE 1; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CELL LEVEL; CELL STIMULATION; CHEMICAL REACTION; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GLUTATHIONYLATION; HISTONE PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN INDUCTION; PROTEIN MODIFICATION; PROTEIN SECRETION; PROTEIN TARGETING; SMOOTH MUSCLE FIBER;

ADULT; AGED; CELLS, CULTURED; CHEMOKINE CCL5; CHEMOKINES, CC; DIAMIDE; FUMARATES; GLUTATHIONE; HISTONES; HUMANS; I-KAPPA B PROTEINS; MALE; MIDDLE AGED; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; PHOSPHORYLATION; RESPIRATORY FUNCTION TESTS; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SULFHYDRYL REAGENTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 82555195203     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00129610     Document Type: Article

References (30)

1. Kay AB. The role of eosinophils in the pathogenesis of asthma. Trends Mol Med 2005; 11: 148-152.
2. Ying S, Meng Q, Zeibecoglou K, et al. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (intrinsic) asthmatics. J Immunol 1999; 163: 6321-6329.
3. Berkman N, Krishnan VL, Gilbey T, et al. Expression of RANTES mRNA and protein in airways of patients with mild asthma. Am J Respir Crit Care Med 1996; 154: 1804-1811. (Pubitemid 26424954)
4. Li D, Wang D, Griffiths-Johnson DA, et al. Eotaxin protein and gene expression in guinea-pig lungs: constitutive expression and upregulation after allergen challenge. Eur Respir J 1997; 10: 1946-1954. (Pubitemid 27406423)
5. Thomas PS, Yates DH, Barnes PJ. Tumour necrosis factor-α increases airway responsiveness and sputum neutrophilia in normal human subjects. Am J Respir Crit Care Med 1995; 152: 76-80.
6. Brightling CE, Bradding P, Symon FA, et al. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002; 346: 1699-1705. (Pubitemid 34547483)
7. Seidel P, Merfort I, Hughes JM, et al. Dimethylfumarate inhibits NF-κB function at multiple levels to limit airway smooth muscle cell cytokine secretion. Am J Physiol Lung Cell Mol Physiol 2009; 297: L326-L339.
8. Nie M, Knox AJ, Pang LH. β-2-adrenoceptor agonists, like glucocorticoids, repress eotaxin gene transcription by selective inhibition of histone H4 acetylation. J Immunol 2005; 175: 478-486. (Pubitemid 40884352)
9. Chen LF, Greene WC. Shaping the nuclear action of NF-κB. Nat Rev Mol Cell Biol 2004; 5: 392-401.
10. Kil IS, Kim SY, Park JW. Glutathionylation regulates IκB. Biochem Biophys Res Commun 2008; 15, 373: 169-173.
11. Gilge JL, Fisher M, Chai YC. The effect of oxidant and the nonoxidant alteration of cellular thiol concentration on the formation of protein mixed-disulfides in HEK 293 cells. PLoS One 2008; 3: e4015.
12. Liao BC, Hsieh CW, Lin YC, et al. The glutaredoxin/glutathione system modulates NF-κB activity by glutathionylation of p65 in cinnamaldehyde-treated endothelial cells. Toxicol Sci 2010; 116: 151-163.
13. Pineda-Molina E, Klatt P, Vázquez J, et al. Glutathionylation of the p50 subunit of NF-κB: a mechanism for redox-induced inhibition of DNA binding. Biochemistry 2001; 40: 14134-14142. (Pubitemid 33081616)
14. Thiessen A, Schmidt MM, Dringen R. Fumaric acid dialkyl esters deprive cultured rat oligodendroglial cells of glutathione and upregulate the expression of heme oxygenase 1. Neurosci Lett 2010; 475: 56-60.
15. Wierinckx A, Brevé J, Mercier D, et al. Detoxication enzyme inducers modify cytokine production in rat mixed glial cells. J Neuroimmunol 2005; 166: 132-143. (Pubitemid 41074663)
16. Lehmann JC, Listopad JJ, Rentzsch CU, et al. Dimethylfumarate induces immunosuppression via glutathione depletion and subsequent induction of heme oxygenase 1. J Invest Dermatol 2007; 127: 835-845. (Pubitemid 46434667)
17. Kouzarides T. Chromatin modifications and their function. Cell 2007; 128: 693-705. (Pubitemid 46273577)
18. Ahn YT, Huang B, McPherson L, et al. Dynamic interplay of transcriptional machinery and chromatin regulates "late" expression of the chemokine RANTES in T lymphocytes. Mol Cell Biol 2007; 27: 253-266. (Pubitemid 46013249)
19. Saccani S, Pantano S, Natoli G. p38-dependent marking of inflammatory genes for increased NF-κB recruitment. Nat Immunol 2002; 3: 69-75. (Pubitemid 34065620)
20. Vermeulen L, Berghe WV, Beck IM, et al. The versatile role of MSKs in transcriptional regulation. Trends Biochem Sci 2009; 34: 311-318.
21. Gesser B, Johansen C, Rasmussen MK, et al. Dimethylfumarate specifically inhibits the mitogen and stress-activated kinases 1 and 2 (MSK1/2): possible role for its anti-psoriatic effect. J Invest Dermatol 2007; 127: 2129-2137. (Pubitemid 47258496)
22. Johnson PRA, Roth M, Tamm M, et al. Airway smooth muscle cell proliferation is increased in asthma. Am J Respir Crit Care Med 2001; 164: 474-477. (Pubitemid 32778219)
23. Quante T, Ng YC, Ramsay EE, et al. Corticosteroids reduce IL-6 in ASM cells via up-regulation of MKP-1. Am J Respir Cell Mol Biol 2008; 39: 208-217.
24. Janssen-Heininger YM, Poynter ME, Aesif SW, et al. Nuclear factor κB, airway epithelium, and asthma: avenues for redox control. Proc Am Thorac Soc 2009; 6: 249-255.
25. Mihm S, Galter D, Dröge W. Modulation of transcription factor NFκB activity by intracellular glutathione levels and by variations of the extracellular cysteine supply. FASEB J 1995; 9: 246-252.
26. Lou H, Kaplowitz N. Glutathione depletion down-regulates tumour necrosis factor α-induced NF-κB activity via IκB kinase-dependent and -independent mechanisms. J Biol Chem 2007; 282: 29470-29481. (Pubitemid 350043388)
27. Reynaert NL, van der Vliet A, Guala AS, et al. Dynamic redox control of NF-κB through glutaredoxin-regulated S-glutathionylation of inhibitory κB kinase b. Proc Natl Acad Sci USA 2006; 103: 13086-13091. (Pubitemid 44338920)
28. McCoy CE, Campbell DG, Deak M, et al. MSK1 activity is controlled by multiple phosphorylation sites. Biochem J 2005; 387: 507-517. (Pubitemid 40571238)
29. Kim SM, Park JG, Baek WK, et al. Cadmium specifically induces MKP-1 expression via the glutathione depletion-mediated p38 MAPK activation in C6 glioma cells. Neurosci Lett 2008; 440: 289-293.
30. Kinney CM, Chandrasekharan UM, Yang L, et al. Histone H3 as a novel substrate for MAP kinase phosphatase-1. Am J Physiol Cell Physiol 2009; 296: C242-C249.